SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

India's pharma exports up by 10.5% to $1.26 billion in April

13 May 2014 Evaluate

India’s pharmaceutical exports grew by 10.5 percent to $1.26 billion in the month of April from a year earlier. The Pharmaceuticals Export Promotion Council (Pharmexcil) expects a healthy rate of growth in pharma exports at around 12 percent in current fiscal on the back of rising demand of drugs from African countries. The government has set pharma exports target for current fiscal at $25 billion.

In the previous fiscal, Indian pharma exports grew at a slowest pace in 15 years at 1.2 percent to $14.84 billion amid growing tension with the US over intellectual property rights (IPR) related issues. The previous slowest growth rate for domestic pharma exports was in FY10 at 5.9 percent. The US accounts for about 25 percent of India's pharma exports. Presently, US pharma industry is contending that India's IPR laws particularly with regard to pharma sector discriminate American firms and put pressure on the US government to take actions against India. Further, major domestic players such as Ranbaxy and Wockhardt are facing imports alerts on some major plants issued by the US Food and Drug Administration (USFDA) in 2013.

Indian is the top exporters to the Commonwealth of Independent States (CIS) region countries. The prevailing political turmoil between Ukraine and Russia which has led to political and economic tensions in the Crimean region, has also hit the businesses of leading Indian pharmaceutical companies.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×